Prescriber is the leading UK journal for healthcare professionals focussing on prescribing and medicines management. The journal features articles on all areas of therapeutics and prescribing policy and is fully peer reviewed. The content is relevant and of interest to all prescribers and prescribing policy makers including GPs, pharmacists, nurses and hospital specialists. Access to all content is free to healthcare professionals following registration.Sign up for e-alerts and print copies

Latest News

Drug treatments for chronic plaque psoriasis compared

A Cochrane systematic review has been published, comparing the efficacy of systemic pharmacological treatments for chronic plaque psoriasis (Cochrane Database...Read more

Licence recommended for first oral GLP-1 agonist

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended the granting of a marketing authorisation for oral semaglutide (Rybelsus),...Read more

New lipid-lowering drug bempedoic acid for primary hypercholesterolaemia

The CHMP has recommended a marketing authorisation for bempedoic acid (Nilemdo), a novel lipid-lowering therapy for the treatment of primary...Read more

CHMP recommends topical crisaborole for atopic dermatitis

A marketing authorisation has also been recommended by the CHMP for Staquis, a new non-steroidal topical treatment for atopic dermatitis (eczema). Staquis is...Read more

NICE rejects esketamine nasal spray in draft guidance

In recently published draft guidance for consultation, NICE has not recommended esketamine nasal spray (Spravato) within its marketing authorisation for the...Read more

Featured Articles

Drug discovery and development: the final frontier
Space offers a unique environment for studying disease processes, as well as for drug discovery and development. Mark Greener discusses how research conducted in microgravity in space is allowing medicine to boldly go where it has never gone before.
Click here to view

Managing the symptoms of Huntington’s disease
Unfortunately, there is currently no cure for Huntington’s disease and management is therefore focused on alleviating symptoms. This article discusses the treatment options available for managing the motor and psychiatric symptoms associated with Huntington’s disease.
Click here to view

Investigation and management of giant cell arteritis
Early recognition of the symptoms of giant cell arteritis (GCA), followed by urgent referral and treatment are important in order to prevent possible sight loss. This article discusses the clinical presentation of GCA, the investigations needed to aid diagnosis, and recommended management.
Click here to view

Web design and marketing agency Leamington Spa